Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
39
Number of overlapping holdings
11.5%
% of FHLC's 368 holdings also in XPH
95.1%
% of XPH's 41 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 5.7% | 4.0% | 4.0% |
|
ELI LILLY & CO | 11.6% | 3.7% | 3.7% |
|
MERCK & CO. INC. | 5.3% | 3.6% | 3.6% |
|
PFIZER INC | 2.5% | 4.1% | 2.5% |
|
BRISTOL-MYERS SQUIBB CO | 1.4% | 3.9% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to XPH
|
ELI LILLY & CO | 7.9% |
|
UNITEDHEALTH GROUP INC | 7.5% |
|
ABBVIE INC | 4.9% |
|
THERMO FISHER SCIENTIFIC INC | 3.6% |
|
ABBOTT LABORATORIES | 2.9% |
|
DANAHER CORP | 2.9% |
|
AMGEN INC | 2.6% |
|
INTUITIVE SURGICAL INC | 2.5% |
|
ELEVANCE HEALTH INC | 2.0% |
|
VERTEX PHARMACEUTICALS INC | 2.0% |
FHLC Underweight Relative to XPH
|
AXSOME THERAPEUTICS, INC. | -4.3% |
|
VIATRIS, INC. | -4.2% |
|
INTRA-CELLULAR THERAPIES INC | -4.0% |
 |
PERRIGO CO | -3.8% |
|
ORGANON & CO. | -3.8% |
|
ROYALTY PHARMA PLC CLASS A | -3.7% |
|
CATALENT INC | -3.7% |
|
CORCEPT THERAPEUTICS INC | -3.6% |
|
JAZZ PHARMACEUTICALS PLC | -3.5% |
|
ARVINAS, INC. | -3.4% |